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Abstract
Insulin-like growth factor-I (IGF-I) and thioredoxin are regulated by gonadal steroids in the female reproductive tract of many
species. Oestradiol regulates IGF-I and thioredoxin mRNA levels in the reproductive tract of prepubertal lambs. The
physiological status (different endocrine environment) may affect the sensitivity of the reproductive tract to oestradiol and
progesterone. We studied the effects of different endocrine milieus (late-follicular and luteal phases of the oestrous cycle, and
ovariectomy before or after puberty) on the expression of IGF-I, thioredoxin, oestrogen receptor α (ERα) and progesterone
receptor (PR) in sheep. The mRNA levels were determined by a solution hybridisation technique. In the uterus the levels of
ERα, PR and thioredoxin mRNA were higher in the late-follicular phase group than in the other three groups, and IGF-I mRNA
was high during both the late-follicular and the luteal phases. In the cervix only PR mRNA was significantly higher in the ewes in
the late-follicular phase than in the other groups. In the oviducts the levels of thioredoxin and ERα mRNA were highest in the
ovariectomised adult ewes, and thioredoxin mRNA was higher than the levels found in the ewes in the late-follicular phase. The
IGF-I mRNA levels in the oviduct did not differ between any of the groups. The transcripts of IGF-I, thioredoxin, ERα and PR,
varied according to the physiological status and also along the female reproductive tract, suggesting that the regulation of the
mRNA levels of these factors by the steroid environment is tissue specific.
Koncentrationen av insulin-like growth factor-I (IGF-I) och thioredoxin regleras hos många arter i honors reproduktionsorgan
av könssteroider. Sålunda reglerar östradiol IGF-I och thioredoxin mRNA i reproduktionsorganen hos prepubertala lamm.
Djurets fysiologiska status (dvs den endokrina miljön) kan påverka känsligheten hos reproduktionsorganen för östradiol och
progesteron. Vi studerade effekterna av olika endokrina miljöer (sen follikelfas och lutealfas i östruscykeln, samt ovariektomi
före och efter puberteten) på uttrycket av IGF-I, thioredoxin, östrogenreceptor α (ERα) och progesteronreceptorn (PR) hos
får. Lösningshybridisering användes för att bestämma mRNA nivåerna. I livmodern var mRNA koncentrationen för ERα, PR och
thioredoxin högre i sen follikelfas än i de andra tre grupperna och IGF-I mRNA nivån var hög både under sen follikelfas och i
lutealfas. PR mRNA i cervix var signifikant högre hos tackorna under sen follikelfas än i de andra grupperna. I äggledarna var
mRNA nivåerna av thioredoxin och ERα högst i de djur som ovariektomerats som vuxna, och thioredoxin mRNA var högre än
hos tackorna under sen follikelfas. Det förelåg ingen skillnad vad gäller IGF-I mRNA nivåerna i äggledaren mellan någon av
grupperna. IGF-I, thioredoxin, ERα och PR mRNA nivåerna varierade beroende på fysiologisk status och morfologisk lokalisation
i reproduktionsorganen. Detta tyder på att steroidhormonernas reglering av dessa faktorers mRNA uttryck också är
vävnadsspecifik.
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1. Introduction
Oestrogens and progestins secreted by the ovaries are the
major modulators of the female reproductive tract func-
tions. Their actions are primarily mediated via binding to
specific intracellular receptors in the target cells, and sub-
sequent stimulation of gene transcription [1]. The tissue
response is determined by both the concentration of the
sex steroids in the circulation and the concentration of
their high affinity receptors in the tissues [2]. Further-
more, the steroids regulate the sex steroid receptor content
along the reproductive tract in a specific manner [3].
Growth factors (e.g. insulin-like growth factor-I, IGF-I)
and other bioactive molecules, such as thioredoxin, medi-
ate many of the sex steroid actions on the reproductive
tract [4-6]. IGF-I has multiple effects on cellular growth
and metabolism [7], and is the major paracrine growth
factor secreted by uterine stroma [8]. IGF-I promotes cel-
lular mitosis and differentiation in the endometrium [9].
There is direct evidence that IGF-I plays a significant role
in reproductive tract development [10]. In the uterus, IGF-
I expression is mainly regulated by oestrogens [9,11,12].
Oestradiol treatment induced IGF-I mRNA expression in
the oviducts, uterus and cervix of prepubertal ewes [6],
while progesterone treatment affected IGF-I mRNA
expression only in the uterus [13].
Thioredoxin is a small multifunctional protein (12 kDa)
that acts as a hydrogen donor to the enzyme ribonucle-
otide reductase that reduces ribonucleotides to deoxyribo-
nucleotides and, thus, is essential for DNA synthesis [14].
The biological functions of thioredoxin in the uterus are
likely to be the same as in other cells, and are probably
coupled to the mitogenic activity in the uterus and the
subsequent DNA, RNA and protein synthesis [15,16].
Oestradiol increases the thioredoxin mRNA levels in the
rat uterus, and the oestradiol level is positively correlated
to cervical thioredoxin mRNA levels in non-pregnant
women [17,18]. Studies in sheep are scarce, but oestradiol
has been shown to stimulate thioredoxin expression also
in the oviducts, uterus and cervix of prepubertal lambs [6].
The regulation of IGF-I and thioredoxin expression along
the reproductive tract of intact prepubertal lambs has
been studied after oestradiol/progesterone treatment
[6,13]. Most studies on oestradiol and progesterone regu-
lation of uterine gene expression have been conducted
using ovariectomised ewes or lambs, or anoestrous ewes,
with steroid replacement/treatment. These experimental
paradigms do not give a clear picture about gene expres-
sion under naturally occurring conditions. The endocrine
environment differs according to the physiological status
of the animal and this may affect the sensitivity of the
reproductive tract to oestradiol and progesterone (e.g. oes-
trogen and progesterone receptors) and thus, the biologi-
cal response of the tissue to these steroid hormones. Since
IGF-I and thioredoxin expression is affected by steroid
hormones, we hypothesise that the relative levels of the
IGF-I and thioredoxin transcripts will change under differ-
ing physiological or endocrine conditions along the
reproductive tract (oviducts, uterus and cervix). Therefore,
our main objective was to determine the expression of
IGF-I and thioredoxin in the reproductive tract under dif-
ferent endocrine milieus (late-follicular and luteal phases
of the oestrous cycle and ovariectomy before and after
puberty), which to our knowledge is the first report in
sheep. Oestrogen receptor (ER) and progesterone receptor
(PR) expression along the reproductive tract was also
determined and was used as an index of tissue sensitivity
to steroid hormones [2].
2. Materials and methods
2.1. Animals and treatments
This experiment was carried out in Uruguay in the breed-
ing season (May). Eighteen intact and ovariectomised
(OVX) Corriedale ewes were used. Oestrus was synchro-
nised in the intact ewes (intra-vaginal sponges impreg-
nated with medroxy-progesterone acetate for 12 days).
Oestrus was checked twice daily with a ram from 24 until
72 h after sponge withdrawal. Four different groups were
formed according to gonadal status and age at ovariec-
tomy: intact ewes in late-follicular phase (OVF, n = 4) and
in luteal phase (OVL, n = 4), ovariectomised adult ewes
(OVXa, n = 5) and ovariectomised lambs (OVXy, n = 5).
The late-follicular phase group was selected to study the
effects of endogenous oestradiol on the expression of IGF-
I and thioredoxin in the reproductive tract, while the
luteal phase group was selected to study the effects of
endogenous progesterone. Follicular and luteal phases
were selected to investigate the opposite endogenous
endocrine profiles (high oestradiol-low progesterone vs.
low oestradiol-high progesterone). The ovariectomised
adult ewes were included as sex steroids-free control ani-
mals in contrast to the natural occurring sex steroid levels
during the follicular and luteal phases of the oestrous
cycle. The ovariectomized lambs had not gone through
puberty and therefore represent pre-exposure expression
of the mRNA's investigated. The adult ewes were more
than 3 years old, and the lambs were all 8.5 months old,
when sacrificed. Ovariectomy was done 5.5 months
(November) prior to sacrifice except in three lambs in
which it was done two months (March) prior to sacrifice.
All of the animals were accustomed to frequent handling.
All animal experimentation was performed in compliance
with regulations set by the National Board for Laboratory
Animals (Swedish University of Agricultural Sciences, Fac-
ulty of Veterinary Medicine, Uppsala, Sweden).
The animals were weighed and sacrificed and the repro-
ductive tracts were obtained. Animals of the same groupActa Veterinaria Scandinavica 2006, 1:5 http://www.actavetscand.com/content/1/1/5
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were sacrificed on the same day. Blood samples were col-
lected prior to slaughter to record the hormonal status of
the animals. The hormones were analysed by previously
validated radioimmunoassays (Coat-A-Count radioim-
munoassay kits, Diagnostic Products Corporation, Los
Angeles, CA, USA) (progesterone: [19]; oestradiol: [20]).
Progesterone was analysed in the samples before sacrifice
of each animal, and in the daily samples from the intact
ewes from the day of sponge withdrawal onward. All of
the samples were run in the same assay, and the intra-
assay coefficients of variation for three control samples
(low 3.1 nmol/L, medium 28.1 nmol/L and high 45.0
nmol/L) were 0.5%, 8.4% and 0.7%, respectively. The
analytical detection limit of the assay was 0.35 nmol/L.
Oestradiol was determined in the samples before sacrifice
of each animal and in the daily samples from the intact
ewes from sponge withdrawal onward. The intra-assay
coefficients of variation for three control samples (low 7.1
pmol/L, medium 47.5 pmol/L and high 128.8 pmol/L)
were 11.9%, 7.3% and 7.2%, respectively. The corre-
sponding inter-assay coefficients of variation were 15.1%,
12.6% and 10.9%, respectively. The analytical detection
limit of the assay was 2.7 pmol/L. Ewes of the OVF group
were sacrificed 72 h after sponge withdrawal (i.e. 24 h
after first observation of oestrus) and ewes of OVL group
were sacrificed 12 days after sponge withdrawal. The
reproductive tract was dissected and oviducts, uterus and
cervix were separated and weighed. One oviduct of each
animal was used for analysis and from each cervix approx-
imately 2 to 3 g of tissue was taken from the centre. Since
we have previously demonstrated that ER and PR concen-
trations are different according to the region of the uterine
horn studied [20], the uteri were divided in Upper Zone
(cranial portion of the uterine cornua beginning at the
uterotubal junction); Lower Zone (caudal portion of the
uterine cornua adjacent to the uterocervical junction); and
Middle Zone (medial to Upper and Lower zones in the
uterine cornua). The uterine samples were not further dis-
sected. The tissues were frozen in liquid nitrogen and
stored at -80°C until preparation for solution hybridisa-
tion analyses.
2.2. TNA preparation and mRNA determination
The tissue samples were homogenised and total nucleic
acids (TNA) prepared by digestion of the homogenate
with proteinase K in a SDS-containing buffer, followed by
subsequent extraction as previously described [21]. The
DNA content of the TNA samples was determined by a
fluorometric assay at the wavelength 458 nm with
Hoechst Dye 33258 [22]. A solution hybridisation assay
for specific mRNA determinations was used and per-
formed as before [21]. In short: TNA samples were hybrid-
ised with in vitro 35S-UTP labelled RNA probes (~20.000
cpm/incubation) at 70°C. Incubations were performed in
duplicates. After overnight incubation each sample was
treated with an RNase containing buffer, to digest non-
hybridised RNA. The following modification was done in
order to quantify the mRNAs. The labelled hybrids pro-
tected from RNase digestion were precipitated by addition
of trichloroacetic acid and collected on filters (Whatman
GF/C, Whatman International Ltd, Maidstone, England).
The radioactivity on the filters was monitored in a scintil-
lation counter and the results were compared with a
standard curve of known amounts of in vitro synthesized
mRNA complementary to the probe used. Every set of tis-
sue samples was run in one assay. Results are expressed as
amol (10-18) mRNA/µg DNA in the TNA samples. The val-
idation of quantification by solution hybridization has
been shown previously [23].
2.3. Hybridisation probes
The probe used for IGF-I mRNA determinations was
derived from a 775 bp RsaI-EcoRI fragment cDNA of the
human insulin-like growth factor-I (IGF-I). The fragment
was cloned into the HincII and EcoRI sites of a Bluescript
KS vector. Restriction of this vector with XhoI allows the
synthesis of a cRNA probe. The probe used for the thiore-
doxin mRNA determinations was derived from a genomic
clone of human thioredoxin cDNA [24]. A fragment of
315 bp representing the 105 amino acids in the open-
reading frame of the human thioredoxin gene was sub-
cloned into a pGEM 3Z vector. Two subclones with oppo-
site orientations were selected and digested with SmaI.
Sense and anti-sense RNA were obtained using T7 RNA
polymerase. A northern blot where the human derived
thioredoxin anti-sense probe was hybridised to ovine
RNA exhibited a single band at approximately 600 base-
pairs [6]. The probes used for oERα and oPR mRNA deter-
minations were derived from plasmids containing 360 or
314 bp cDNAs from the ovine ER and PR, respectively,
and were kindly supplied by Dr. N. Ing, Texas University,
TX, USA [25]. Restriction of the vector (pGEM4Z) contain-
ing a fragment of the oER cDNA with EcoRI allows the syn-
thesis of an anti-sense RNA probe using T7 RNA
polymerase. Restriction of the vector (pCRII) containing a
fragment of the oPR cDNA with HindIII allows the synthe-
sis of an anti-sense RNA probe using T7 RNA polymerase.
2.4. Statistics
Analysis of variance of the data was done with a statistical
package [26] using the MIXED procedure with the Tukey-
Kramer test. The two main effects studied were group and
tissue, and their interaction group*tissue, and animal was in
the error term. The groups within each tissue were com-
pared using orthogonal contrasts. The variables analysed
were ERα, PR, IGF-I and thioredoxin mRNA, and the tis-
sue weight of the uteri, oviducts and cervix. No differences
were found in the transcripts among the uterine zones (P
> 0.10), therefore the data was pooled and presented asActa Veterinaria Scandinavica 2006, 1:5 http://www.actavetscand.com/content/1/1/5
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whole uterus samples. The level of significance was P <
0.05 and the results are expressed as mean ± SEM.
3. Results
3.1. Body weight and sex steroid levels at sacrifice
Table 1 displays the mean (± SEM) body weight of the ani-
mals of each group, as well as the oestradiol and proges-
terone levels at the time of sacrifice. The lambs weighed
significantly less than the adult ewes and the hormones
were in accordance with the reproductive status of the ani-
mals (Fig. 1, Table 1). All of the intact ewes had shown
oestrus signs except for one ewe in the OVL group, never-
theless all of OVL ewes had a corpus luteum at the time of
sacrifice. The ovaries of three OVF ewes presented a
mature follicle and one OVF ewe had ovulated at the time
of sacrifice.
3.2. Tissue weights
The uterine weight was higher in the intact ewes than in
the ovariectomised animals (P < 0.0001). The weights of
cervix and oviducts were highest in the ewes in the late-
follicular phase, intermediate in the ewes in the luteal
phase and the ovariectomised ewes, and lowest in the ova-
riectomised lambs (P < 0.01) (Table 2).
3.3. General effects of treatments on mRNA
The effects of group and tissue were significant as well as
their interaction for ERα, PR and IGR-I mRNA (P <
0.0001). For thioredoxin mRNA the effects were also sig-
nificant (group: P = 0.0482; tissue: P = 0.0002; and
group*tissue: P = 0.0028).
3.4. ERα mRNA
In the oviduct, the ovariectomised adult ewes showed the
highest levels of ERα mRNA, which were significantly dif-
ferent from those of the ewes in the luteal phase and the
Mean (± SEM) progesterone (nmol/L) and oestradiol (pmol/L) profiles in the intact synchronised ewes before slaughter Figure 1
Mean (± SEM) progesterone (nmol/L) and oestradiol (pmol/L) profiles in the intact synchronised ewes before slaughter. Solid 
triangles and dots: OVF group (slaughtered on day 1 relative to standing oestrus); open triangles and dots: OFL group (slaugh-
tered on day 11 relative to standing oestrus).
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ovariectomised lambs (Fig. 2A). In the uterus, however,
the levels of ERα mRNA were higher in the late-follicular
phase group than in the other three groups (Fig. 2B). In
the cervix the ewes in the late-follicular phase had signifi-
cantly higher levels of ERα mRNA than the ovariect-
omised ewes (Fig. 2C).
3.5. PR mRNA
In the oviducts the PR mRNA levels of the ewes in the late-
follicular phase were only significantly higher than those
of the ovariectomised lambs (Fig. 2D). In the uterus (Fig.
2E) as well as the cervix (Fig. 2F) the levels of PR mRNA
were higher in the late-follicular phase group compared to
the other three groups.
3.6. IGF-I mRNA
The IGF-I mRNA levels in the oviduct were not different
between any of the groups (Fig. 2G). In the uterus the lev-
els of IGF-I mRNA in the intact ewes (OVF and OVL) were
higher than those of the ovariectomised ewes and lambs
(Fig. 2H). The IGF-I mRNA level in the cervix of the ova-
riectomised lambs was lower than that of the adult ewes
(late-follicular and luteal phase, and ovariectomised)
(Fig. 2I).
3.7. Thioredoxin mRNA
In the oviducts the ovariectomised adult ewes had the
highest levels of thioredoxin mRNA, which were signifi-
cantly different from the ewes in the late-follicular phase
and the ovariectomised lambs (Fig. 2J). In the uterus (Fig.
2K) as well as the cervix (Fig. 2L) the levels of thioredoxin
mRNA were higher in the late-follicular phase group than
in the other three groups, although the levels of thiore-
doxin mRNA in the cervix the ewes in the luteal phase
were not different from the ones in the late-follicular
phase.
4. Discussion
This is the first report on IGF-I and thioredoxin expres-
sion, studied together with transcripts of the main regula-
tors of uterine function (ERα and PR), under different
endocrine environments in the reproductive tract of
sheep. The virtue of this study is that no exogenous hor-
mones were used, and therefore, the differences observed
reflect the physiological status of the animals. The regula-
tion of the transcripts of IGF-I, thioredoxin, ERα and PR,
was most likely dependent on the endogenous endocrine
status of the ewes, and for each transcript this regulation
varied in the different regions of the reproductive tract.
The oviducts weighed more in the late-follicular phase
(Table 2), but this was not associated with the targeted
mRNAs since they were either similar (ERα, PR and IGF-I)
or lower (thioredoxin) than those of the ovariectomised
adult ewes and not different from the ewes in the luteal
phase in any of the cases (Figure 2). Similarly, treatment
of prepubertal lambs with oestradiol also resulted in a
weight increase of the oviducts [20], which was not
accompanied with increases of ERα, PR and IGF-I mRNA
[13]. If oestrogens were responsible for the higher oviduct
weight, the effect on the transcripts was probably short-
lived and therefore not seen in this study. This is also sup-
ported by another study [6] where IGF-I mRNA and
thioredoxin mRNA were maximal 12 h after oestradiol
treatment, but no differences were detected after 24 h.
Highest IGF-I expression (by in situ hybridisation) in
Table 1: Animal groups, number (n) of animals per group, mean (± SEM) body weight (BW) (Kg) and the levels of oestradiol (pmol/l) 
and progesterone (nmol/l) at the time of sacrifice
Group n BW (kg) (SEM) Oestradiol 
(pmol/l)
(SEM) Progesterone 
(nmol/l)
(SEM)
OVF 4 39 (2.0) 9.0 (1.2) 0.4 (0.0)
OVL 4 40 (3.0) 6.5 (0.7) 8.6 (1.7)
OVXa 5 42 (1.2) 4.6 (0.7) 0.4 (0.0)
OVXy 5 24 (2.4) 4.5 (0.7) 0.4 (0.0)
OVF: ewes in late-follicular phase, OVL: ewes in luteal phase, OVXa: ewes ovariectomised in adulthood, and OVXy: ovariectomised lambs.
Table 2: Mean (± SEM) tissue weights (g) in ewes in the late-follicular and luteal phases and ovariectomised ewes and lambs
Group Oviduct weight (SEM) Uterine weight (SEM) Cervical weight (SEM)
OVF 3.0a (0.31) 48a (7.5) 17.6a (1.62)
OVL 1.5b (0.18) 37a (3.3) 7.2b (0.36)
OVXa 1.5b (0.12) 12b (1.4) 6.9b (1.04)
OVXy 0.6c (0.10) 3b (0.3) 2.0c (0.30)
The different letters a, b and c in columns indicates statistical significance (P < 0.01). OVF: ewes in late-follicular phase, OVL: ewes in luteal phase, 
OVXa: ewes ovariectomised in adulthood, and OVXy: ovariectomised lambs.Acta Veterinaria Scandinavica 2006, 1:5 http://www.actavetscand.com/content/1/1/5
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Mean (± SEM) concentrations of ERα (A, B and C), PR (D, E and F), IGF-I (G, H and I), and thioredoxin (J, K and L) mRNA  (amol/µg DNA) in oviducts (A, D, G and J), uterus (B, E, H and K) and cervix (C, F, I and L) of ewes in the late-follicular (OVF)  and in the luteal (OVL) phase, ovariectomised ewes (OVXa) and ovariectomised lambs (OVXy) Figure 2
Mean (± SEM) concentrations of ERα (A, B and C), PR (D, E and F), IGF-I (G, H and I), and thioredoxin (J, K and L) mRNA 
(amol/µg DNA) in oviducts (A, D, G and J), uterus (B, E, H and K) and cervix (C, F, I and L) of ewes in the late-follicular (OVF) 
and in the luteal (OVL) phase, ovariectomised ewes (OVXa) and ovariectomised lambs (OVXy). Within each graph bars with 
different letter designations are significantly different, P < 0.05.
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ovine oviducts has been observed 48–60 h after a prostag-
landin analogue injection coinciding with standing
oestrus [27].
The uterine weight of the ewes in the late-follicular phase
and the high IGF-I mRNA levels in the uterus confirmed
the earlier observations on the effects of oestradiol on
uterine weight and IGF-I mRNA in ewe lambs [6,20]. Ste-
venson et al. [4] have found highest IGF-I expression in
sheep uterus during oestrus using in situ hybridisation, as
compared to other phases of the oestrous cycle. IGF-I
expression and subsequent uterine growth are induced by
oestradiol [12], which was reflected in our study in the
high uterine IGF-I mRNA levels of the ewes in the late-fol-
licular phase. No classical oestrogen responsive element
(ERE) has been found in the promoter of the IGF-I gene
[28], but still oestrogen regulates its expression [6]. In
agreement with the role of thioredoxin as a growth pro-
moter of the uterus, its mRNA levels were highest in the
ewes in the late-follicular phase. Thioredoxin expression
was increased during oestrus also in mouse reproductive
tissues [29]. The mRNA levels of ERα and PR in the uterus
were as expected, higher in the late-follicular phase than
in the luteal phase [30].
In contrast to the uterus, the levels of IGF-I mRNA were
not associated with the higher weight of the cervix in the
late-follicular phase compared to the other groups (Figure
2). The oestradiol levels had peaked during the two days
before tissue collection (Figure 1), and this might explain
the lack of differences in cervical IGF-I mRNA levels
between the ewes in the late-follicular and luteal phase
and the ovariectomised ewes. In an earlier study Sahlin et
al. [6] reported a prominent though transient induction
(only the first 24 h of a three-day-treatment) of IGF-I
mRNA in the cervix of oestradiol treated prepubertal
lambs. In the present study, ewes in the late-follicular
phase (associated with high oestrogen levels) had high
steady state levels of ERα, PR and thioredoxin mRNAs in
the cervix.
In the ewes in the luteal phase (under influence of proges-
terone) growth of the uterus was induced, but not of the
cervix or the oviducts. Like oestradiol, progesterone
induces IGF-I expression and uterine growth [12], and
indeed high IGF-I mRNA levels were found in the uterus
of ewes in the luteal phase. Increased endometrial expres-
sion of IGF-I mRNA has also been observed on days 6 and
8 of pregnancy in sheep, when oestrogens are low and
progesterone is high [31]. However, the uterine mRNA
levels of ERα, PR and thioredoxin of the ewes in the luteal
phase were not different from those of the ovariectomised
ewes and lambs. The cervical and oviduct weights of the
ewes in luteal phase were similar to that of the ovariect-
omised ewes and lower than that of the ewes in the late-
follicular phase, suggesting that progesterone did not
induce proliferation of these tissues. The IGF-I mRNA lev-
els in the cervix and oviducts of the ewes in the luteal
phase were not different from those in the ovariectomised
ewes. Meikle et al. [20] observed a similar differential
effect of progesterone on the reproductive tract in imma-
ture ewes. In that study uterine weight increased after pro-
gesterone treatment while the cervical and oviduct
weights remained unchanged, and this was consistent
with the increase in IGF-I mRNA only in the uterus [13].
However, Stevenson et al. [4] did not observe this
increased uterine IGF-I expression during high progester-
one levels in the ewe.
The removal of the ovarian source of sex steroids by ova-
riectomy resulted in a reduction of the cervical, uterine
and oviduct weights as compared with the ewes in the
late-follicular phase. The cervical weight of the ovariect-
omised lambs was lower than ovariectomised ewes, but
the lambs had not reached adult body weight at ovariec-
tomy, so their reproductive tract was probably not com-
pletely developed. Age at ovariectomy (young vs. adult)
affected the transcripts: the relative levels of ERα and
thioredoxin mRNAs were lower in oviducts, and IGF-I
mRNA in the cervix of young animals.
Our results show that the timing and relative levels of the
expression of each transcript under different endocrine
milieus depend on the organ of the reproductive tract,
with the uterus showing the most dramatic and profound
changes. Progesterone receptor, IGF-I, and thioredoxin are
all markers of oestrogen action in the uterus. Under equal
exposure of circulating steroids during the late-follicular
phase (e.g. oestrogen dominance), the transcripts were
stimulated most in the uterus. The regulation of the tran-
scripts was not only tissue specific but also transcript spe-
cific. While uterine and cervical PR mRNA seemed to
follow the pattern of ERα mRNA very well, the regulation
of IGF-I and thioredoxin mRNAs seemed to be less tightly
associated to this pattern, suggesting the participation of
other factors in their regulation. The differential expres-
sion of IGF-I and thioredoxin found in this study could be
due to different intracellular machinery within the differ-
ent cell types, allowing for the specific functions of each
organ despite being exposed to the same peripheral hor-
mone levels. Although not addressed in this study, it is
known that IGF-I, ERα and PR are expressed in a cell type
specific manner and this should be taken into account
since hormone sensitivity of the target tissue depends on
the specific receptor expression and the cross-talk among
different cell types.
In summary, our findings show that IGF-I and thiore-
doxin expression is regulated in a tissue specific manner
along the reproductive tract, as well as ERα and PR expres-Publish with BioMed Central    and   every 
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sion. The differential transcript expression found in the
reproductive tract of sheep under different endocrine
environments in which no exogenous hormones were
used, suggests that the different responses reported in the
literature in hormone treated OVX animals may depend
on the initial expression of the transcripts.
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